Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DEAL OF THE CENTURY! $40million+ for Simple Prepay on SKTO revenue which is already billable. More revenue will be due from the current quarter, and even more when PJ starts online business.
Thanks to SKTO for giving AEGY an amazing boost on Day 1.
BK
To repeat what I sad the other day... AEGY = DEAL OF THE CENTURY.
Management of SKTO expects to collect all of the revenue due them... (shshshssshh it's 10's of millions) beginning when PJ goes live BEFORE THE END OF THE YEAR. There you have it folks. The retirement train is signing up passengers. Are you going to be on it?
BK
Nicely done 420 buyer!
Big day for AEGY folks... Expect some update on the conference call later... I'm thinking any update is a good one.
BK
The BB GoldNApel essay from 10-17-13 is the key to understanding how proprietary Dharmanol revolutionizes cannabinoid treatment of cancer. The BB breakthrough was to medicinalize the healing THC carboxylate, which is the form of THC found in fresh cannabis juice; the juice is non-psychoactive. However, once heated or dried, THC carboxylate becomes psychoactive. That makes medicinalizing THC carboxylate in a stable and preserved form that can be used in a tablet or lozenge with a reasonable shelf life an exceedingly difficult challenge. This long-time challenge was overcome by Dr. Apel who developed the proprietary technology to accomplish that objective.
Formerly, the "whole-plant" cannabis treatment, providing effectively high doses of the powerful cannabinoid complex plus its other important healing components (without unwanted psychoactive side effects that limited dose level) required juicing fresh cannabis and consuming the juice. This regimen, in the doses required, involved the cultivation of 40 to 80 cannabis plants. However, for the very first time, this high dose "whole plant" non-psychoactive cannabis treatment will be available to consumers without the necessity of maintaining a cannabis garden and juicing. The same will now be now be available in Dharmanol tablets and lozenges.
GoldNApel 10-17-13
"All of the politics have forced many researchers to focus on the non-psychoactives, that is why we have so much research on CBD. Also, medical research traditionally utilizes isolated and purified single-molecule medicines for study, as opposed to a blend of similar compounds such as the entire array of cannabinoids and related compounds found in marijuana and hemp.
Because of these two factors, many people attribute specific actions of cannabinoid medicine to specific molecules. THC does that, CBD does this, CBN does something altogether different, etc. While there is certainly a lot of truth in the specific actions of the different cannabinoids against various medical conditions, the ultimate benefit in treating the great majority of conditions that cannabis works well against comes from what we refer to as “whole-plant” medicine.
There are a number of different figures quoted for the number of chemical compounds that may have medicinal benefit in the cannabis plant. I like the number 421. I figure they counted one of them twice. All the anecdotal evidence, as well as some of the scientific research, shows that cannabis medicine works better as a whole-plant preparation, providing the widest array of cannabinoids, terpenes, etc. that the plant has to offer in the medicine.
The exception to this is when psychoactive THC causes unwanted side effects that limit the amount of medicine that a patient can consume. In this case, it is helpful to eliminate the THC, as is the case with medicines focused on the delivery of pure CBD, or consume the THC in it’s carboxylate (non-psychoactive) form, as happens when one juices fresh cannabis plants, or uses Dharmanol™.
Berkeley Bio did not pioneer the use of the carboxylates in cannabis medicine. That honor belongs to Dr. William Courtney of Willits, CA. Another true hero of the movement, Dr. Courtney has been treating patients with fresh cannabis juice for years, and his wonderful results can be seen on a number of videos on YouTube.
The biggest drawback to Dr. Courtney’s work is that a patient must maintain forty to eighty living cannabis plants to get enough juice for the daily treatment. That isn’t that hard to do in Willits, California – the heart of the Emerald Triangle – but it can be impossible for someone who is not deeply immersed in the culture, or lives in another part of the country.
Dr. Apel’s new technology has allowed us to medicinalize the carboxylates, so they can be taken in tablet form, far more convenient than maintaining forty to eighty live cannabis plants. We have been able to extract and stabilize certain components of hemp/cannabis yielding an oil with about 60% mixed cannabinoids and less than 0.2% (point 2 percent) THC. When this concentrate is tableted with 5 mg. of mixed cannabinoids, the amount of THC will be well below that in many of the health food products found on US shelves today.
Along with the 5 mg. of mixed cannabinoid carboxylates, each Dharmanol™ tablet also contains 5 mg. CBD, for a total of 10 mg. of mixed phyto-cannabinoids. Also included is a steam-extracted mixture of a wide array of terpenes and terpenoids, taken from a number of different strains of cannabis.
The medicinal activity of the cannabinoids is enhanced by the naturally-occuring terpenes and terpenoids in the plant. These are the molecules that are responsible for the taste and smell, and they vary greatly from plant to plant. There is the wonderful sweet smell of the strains called “pineapple”, the aroma of blueberry cannabis can be indistinguishable from that of the actual berry, and at the whole opposite end of the spectrum is the aptly named “Skunk #1”, winner of the very first High Times Cannabis Cup, and the marijuana which, in my opinion, provides the happiest high of all.
Certain terpenes and terpenoids found in the cannabis plant, as well as many other plants, have been tested for their medicinal efficacy. And, guess what? The medicinal efficacy of the ones found in cannabis is very, very promising. (Pardon my personal opinion here and let me again note that I will never claim cure until we have double-blind placebo-controlled proof, but I gotta ask myself: “Is there ANY part of this plant that doesn’t fight disease in every possible way it can?” I can’t find one.)
The overall purpose of the Dharmanol™ technology, and the low-dose tablets in particular, is to combine many of the healing factors of the kind herb together into one medicine – a medicine which allows the patient to benefit from phyto-cannabinoid therapy stimulation of the internal cannabinoid receptors on a regular basis, with no THC psychoactivity.
At the opposite end of the spectrum is high dose cannabis therapy with Dharmanol™. The removal of the psychoactivity from larger doses allows consumption of doses far in excess of those recommended by Mr. Simpson. We have been working on appropriate delivery systems for whole-plant extracts and today announced Mary Ann’s Canna-Loz™ product, which makes the recommended gram each day regimen far more palatable. Shortly the Canna-Loz™ will be available in most of the dispensaries that carry YAK edibles, and the lozenges will supplement the Organakoil that the Care and Hospice Program has been supplying to patients in need for several years."
Here is a LINK to help understand that milligrams and potency are not the same. Also, FYI, 10mg is a max dose of Marinol.
http://www.rxlist.com/marinol-drug.htm
What's more effective for making a nuclear bomb, 5mg of uranium, or 5mg of enriched uranium? Are they the same? At one point perhaps. But now one is useless, and the other blows up houses.
Please prove that 5mg of THC is low.
BK
Hey, I'm not not stopping anyone from treating their beloved and dignified cancer ridden parents with their hemp shorts, they just better be able to answer to the police why fruit of the loom is more effective than Chemo or Dharmanol.
BK
Foolish point. There is no scientific difference between hemp and marijuana. The idea of hemp was created so that hemp products could be marketed during times when the government was concerned. When the THC content in marijuana is bred below a certain potency, it can be called hemp. This point is only FYI because Dharmanol contains high levels of THC for its medicinal effectiveness while suppressing the high effect.
So, to break it down for anyone that may be confused, you cannot smoke your hemp shorts and get high, marijuana makes you high, THC is a cannabinoid, the THC in Dharmanol allows cancer ridden patients to have their death tumors shrunken with very high doses of THC while not getting her stoned. See... THC by definition makes marijuana not the same as hemp.
Now... We can take an even deeper dive into percentages of CBDs, potency of THC, and sterile plants bred for rope, but I think the distinction is clear.
BK
Wrong! It's not hemp.
Not only can BB extract CBDs but BB can also, by secret process, make THC non-psychoactive (THC->THCA). Until BB did it, no one had cracked that nut. (One day, a distinguished prize will be awarded to them for their achievement.) This allows the healing non-psychoactive CBDs (as highlighted in recent CNN special) along with high doses of THC, which is powerfully anti-tumor and anti-cancer as university studies show, to be administered without the issue of psychoactive side effects. This achievement will also allow low-dose and high-dose Dharmanol to be sold as an herbal supplement in a nearby chain grocery or chain pharmacy.
B&W
BK
Not looking good for the MMJ business here... why's it taking so long?
I did some DD on this AEGY & SKTO, + yet - disparity...
I found a hole in the ship, some screws loose, and a whole lot of fruit loops being served. We ALL hold these truths to be self evident... It's nice to have agreement :)
BK
This is one claim that cannot be explained by anyone regardless of your feeling on AEGY.
Fruit loops.
BK
DHARMANOL, the CBD Cancer treatment by SKTO, is very inexpensive! Despite claims to the contrary, it's easy to see just how affordable the treatment is.
BK
I think by Wednesday afternoon, we will be up by at least 100%.
BK
I'd be surprised if they don't go live together. The Simple Prepay is quite... simple to use. It's the many features of PJ being fine tuned right now.
BK
Take a look at the cost of Cancer treatment and then comparemtomthencost of Dharmanol as you estimate it to be.
Look here: http://news.yahoo.com/sky-high-price-chemotherapy-why-cancer-drugs-cost-223821525.html
This 4k per month is an amount that only appears on this board, no where else. It's a highly unreliable estimate. However, I think I will look into how 4k/month for 2 months, for the sake of argument, compares to the cost of treating a cancer patient with chemo.
Just lookin
BK
That much per month forever would be prohibitive but to keep mama alive for an extra month or 2 and possibly cure her in that time... would be something most any family would figure out how to pay for. If a possible cure is available, for a parent, is cost really an objection? "Sorry Mom, this new miracle treatment is more than you can afford. It was nice knowing you." I couldn't say that to my mom.
Just sayin.
BK
Really, all I want to know is when will the PJ site open for business. Everything else is distracting useless information to me.
BK
If a parent of mine was sick with Cancer, and 200 pills a day could possibly cure their Cancer, I'd buy them.
Dharmanol is the future of dignified cancer treatments.
BK
Many Cancer patients could possibly benefit from Dharmanol. It's certainly worth a shot to try to keep our dignified relatives alive, rather than just letting them die, isn't it?
Dharmanol will help some people live longer lives and potentially cure them... The world is about to find out the truth about CBD's.
Just sayin
AEGY PharmaJanes w/ Simple Prepay update!
Expected this week during their sister company SKTO's conference call, this Tuesday Nov. 5th.
On last quarters call we got a PJ update. Expect another peek into the future of MMJ purchasing, on the SKTO conference call, this TUESDAY.
BK
Fun week ahead for SKTO fans. This conference call is huge for us info-wise. We should find out more about PharmaJanes launch plans, more about the SKTO revenue collected, and more of their plans will be revealed to all... I can't wait to hear about their vision for Dharmanol and how big they think it could be.
Exciting times ahead for the profitable pink SKTO.
BK
I will give you that LS. Sometimes SKTO makes me feel like I've invested in a bunch of aimless cross eyed bowlers then I figure out that their plan was perfectly solid all along. The roller coaster ride can be tiring but they deserve some credit!
BK
SKTO has an All Star Collections team. They can manage. We have nothing to worry about.
BK
Oh there's nothing to worry about for investors. Teasing the results early keeps the shorts at bay...
AWESOME!!!
Wow look who SK3/Medical Greens is working with to make sure everything goes smoothly.
Indeglia & Carney
Legal Counsel
1900 Main St.
Suite 300
Irvine, CA, 92614
949-679-9560
http://www.indegliacarney.com
Testimonials:
Client Testimonials
"Top-Notch SEC Attorney"
"Marc Indeglia is a top-notch SEC attorney. He is honest and thorough and he has always stayed on top of the SEC changing regulations as it relates to his clients. Whenever a publicly traded company is looking for new SEC counsel, I always recommend Marc!"
- Jacqueline Borer
Founder & CEO, Borer Financial Communications, Inc.
XBRL, HTML SEC Filing Agents
--------------------------------------------------------------------------------
Reverse Mergers & OTC BBs
"It is a pleasure to recommend Marc Indeglia, a partner of Indeglia & Carney. His firm helped me complete a reverse merger and change of control transaction on the OTC BB. The legal work was thorough and timely and kept the transaction focused on completion within the myriad of regulation. I am also aware of another client of Indeglia & Carney where his firm walked their cross-border transaction between a US OTC BB Company and a private Canadian Company thru to completion. I can confidently recommend Marc and his firm.
- Gordon Samson, CGA
--------------------------------------------------------------------------------
"Strong and Skillful Re: SEC"
"I worked with Marc in a Chapter 11 bankruptcy case. I represented the corporation in its role as Debtor-in-Possession and Marc represented it as a corporate entity. The case was extraordinarily complicated, involving the interplay of SEC and Title 11 law. Marc had a strong understanding of the issues, knowledge of the law, and ability to chart a course to the intended goal. A plan was confirmed that primed the DIP financing in such a way as to satisfy SEC rules while allowing the Debtor to obtain high-risk financing on very favorable terms. He proved his legal abilities by skillfully navigating the rough waters."
--------------------------------------------------------------------------------
SEC Compliance Guidance
"Over the last five+ years I have had the chance to work with Marc in his capacity as a securities lawyer for various clients of mine. He has always demonstrated an eagerness to please and protect his clients and make sure that their SEC filings are timely, compliant and in good form. He is also well-connected in the public arena, which is certainly an added value that his firm brings to the table."
- Seth Farbman
--------------------------------------------------------------------------------
"Mark helped our firm go public in 2001/2002 and we have been with his firm ever since. I&C has deep understanding of the securities law and SEC issues of small cap companies. He has an excellent referral network. Our coporate and M&A work is handled by them too. I recommend their firm for any growth stage small/nano cap company that is tired of paying big firm prices. "March 21, 2011
Top qualities: Great Results, Expert, Good Value
- Matthew Flemming
--------------------------------------------------------------------------------
"Marc was a pleasure to work with on several projects. He is efficient, task-oriented and an expert in his respective field. He has assisted me on IPO's, buyouts, Investment Banking, Mergers & Acquisitions, etc. I highly respect and recommend him as an essential advocate in your corner. Truly the best." March 22, 2011
Top qualities: Great Results, Expert, High Integrity
- Jeffrey J. Carter
hired Marc as a Financial Advisor in 2003, and hired Marc more than once
--------------------------------------------------------------------------------
"Marc is knowledgeable on corporate matters involving start-up and provides useful insights into both legal and financing concerns.
His feedbacks are responsive, timely and ontrack - he doesn't waste a lot of time on inessential matters.
I can recommend his firm wholeheartedly.
David Bennett
Managing Partner
S.E.S Corporation" March 17, 2011
- David Bennett
hired Marc as a Legal in 2005, and hired Marc more than once
--------------------------------------------------------------------------------
"I've had the pleasure of working with Marc for a number of years and would recommend his services with the highest degree of confidence. Marc has consistently provided first-rate service with a detailed knowledge of his space and a finger on the pulse of the legal and financial communities at large. Whether you are an entrepreneur seeking counsel, advice and services for your first capital raise, or an established business with complex securities or financing needs, Marc is the first attorney that I recommend. I look forward to working with Marc again in the future."March 17, 2011
Top qualities: Great Results, Expert, High Integrity
- Damon D'Amore
hired Marc as a Attorney in 2003, and hired Marc more than once
--------------------------------------------------------------------------------
I have worked with Indeglia & Carney for over 2 years. Initially, they were opposing counsel on a complex restructuring transaction involving a pin-off of my operating company from a public vehicle. I was impressed almost immediately by their ability to structure around problems and find solutions to keep the transaction moving forward. Problems arise in every transaction. Most attorneys excel is raising issues. The good ones, such as Marc and Greg, provide solutions. The spin-off transaction finally closed in large part to their efforts. And no matter how difficult things became, their demeanor and tone remained respectful and collegial. I quickly retained them as my legal counsel on various investment banking engagements for my broker dealer and other corporate and securities matters after closing this deal. I have referred, and will continue to refer, their services to my colleagues without hesitation or trepidation.
- Bill Schloth, CEO OnTarget360 Group, Inc.
--------------------------------------------------------------------------------
August 19, 2011
Indeglia and Carney is a firm that does a tremendous job in handling my company's needs. Because its expertise was well known to me (It is not often that one engages a firm that formerly represented a personal adversary.), and because of the know-how, and professionalism I had seen, when the need arose, the choice of Indeglia and Carney was an easy one.
The firm's hard work in getting a fantastic document out within a much expedited time frame recently has made all the difference in the speed in which my company can now move forward with its plans.
Sincerely,
ARNOLD F. SOCK, Esquire
Discovery Carbon Environmental Securities Corporation,
Corporate Secretary, Chief Financial Officer, and Director
It's a great day here in Boston, and later on we will see that it's a great day for the iEquity family...
Play like a champion today.
Tick, tick...
BK
A million shares of AEGY for $700 might actually be the deal of the century. Do your own DD and chack out www.pharmajanes.com
BK
Tomorrow will certainly be a GREAT SKTO day... congrats to all those who held on... IMO the ride is just beginning.
BK
No research? A quick search turned up some evidence. Medical Marijuana, and CBD treatments really work. Here is some international proof...
http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page4
http://www.ncbi.nlm.nih.gov/pubmed/17621270?dopt=Abstract
http://www.sciencedaily.com/releases/2007/04/070417193338.htm
http://scienceblog.cancerresearchuk.org/2012/07/25/cannabis-cannabinoids-and-cancer-the-evidence-so-far/
UNITED KINGDOM
http://www.ncbi.nlm.nih.gov/pubmed/15454482
http://www.ncbi.nlm.nih.gov/pubmed/17583570
http://www.ncbi.nlm.nih.gov/pubmed/17931597
http://www.ncbi.nlm.nih.gov/pubmed/18615640
http://www.ncbi.nlm.nih.gov/pubmed/14640910
UNITED STATES OF AMERICA
http://www.ncbi.nlm.nih.gov/pubmed/20191092
http://www.ncbi.nlm.nih.gov/pubmed/18025276
http://www.ncbi.nlm.nih.gov/pubmed/616322
http://www.ncbi.nlm.nih.gov/pubmed/15753356
http://www.ncbi.nlm.nih.gov/pubmed/12091357
http://www.ncbi.nlm.nih.gov/pubmed/18199524
http://www.ncbi.nlm.nih.gov/pubmed/19887554
http://www.ncbi.nlm.nih.gov/pubmed/19457575
http://www.ncbi.nlm.nih.gov/pubmed/16908594
http://www.ncbi.nlm.nih.gov/pubmed/12130702
http://www.ncbi.nlm.nih.gov/pubmed/11854771
http://www.ncbi.nlm.nih.gov/pubmed/20053780
http://www.ncbi.nlm.nih.gov/pubmed/16754784
http://www.ncbi.nlm.nih.gov/pubmed/20090845
http://www.ncbi.nlm.nih.gov/pubmed/15978942
---------------------------------------------------------------------
GERMANY
http://www.ncbi.nlm.nih.gov/pubmed/12648025
http://www.ncbi.nlm.nih.gov/pubmed/19914218
http://www.ncbi.nlm.nih.gov/pubmed/15026328
http://www.ncbi.nlm.nih.gov/pubmed/16893424
http://www.ncbi.nlm.nih.gov/pubmed/15361550
http://www.ncbi.nlm.nih.gov/pubmed/19889794
http://www.ncbi.nlm.nih.gov/pubmed/19015962
HUNGARY
http://www.ncbi.nlm.nih.gov/pubmed/19608284
ISRAEL
http://www.ncbi.nlm.nih.gov/pubmed/17237277
http://www.ncbi.nlm.nih.gov/pubmed/11586361
http://www.ncbi.nlm.nih.gov/pubmed/14692532
http://www.ncbi.nlm.nih.gov/pubmed/16571653
http://www.ncbi.nlm.nih.gov/pubmed/18286801
http://www.ncbi.nlm.nih.gov/pubmed/16250836
http://www.ncbi.nlm.nih.gov/pubmed/17934890
ITALY
http://www.ncbi.nlm.nih.gov/pubmed/12052046
http://www.ncbi.nlm.nih.gov/pubmed/19189054
http://www.ncbi.nlm.nih.gov/pubmed/18354058
http://www.ncbi.nlm.nih.gov/pubmed/19047095
http://www.ncbi.nlm.nih.gov/pubmed/10913156
http://www.ncbi.nlm.nih.gov/pubmed/9653194
http://www.ncbi.nlm.nih.gov/pubmed/18088200
http://www.ncbi.nlm.nih.gov/pubmed/16909207
http://www.ncbi.nlm.nih.gov/pubmed/17342320
http://www.ncbi.nlm.nih.gov/pubmed/19059457
http://www.ncbi.nlm.nih.gov/pubmed/12723496
http://www.ncbi.nlm.nih.gov/pubmed/19442536
http://www.ncbi.nlm.nih.gov/pubmed/16728591
http://www.ncbi.nlm.nih.gov/pubmed/19539619
http://www.ncbi.nlm.nih.gov/pubmed/16500647
http://www.ncbi.nlm.nih.gov/pubmed/19189659
http://www.ncbi.nlm.nih.gov/pubmed/14617682
http://www.ncbi.nlm.nih.gov/pubmed/18938775
http://www.ncbi.nlm.nih.gov/pubmed/11106791
JAPAN
http://www.ncbi.nlm.nih.gov/pubmed/19394652
KOREA
http://www.ncbi.nlm.nih.gov/pubmed/20336665
NEW ZEALAND
http://www.ncbi.nlm.nih.gov/pubmed/19442435
POLAND
http://www.ncbi.nlm.nih.gov/pubmed/15451022
SAUDI ARABIA
http://www.ncbi.nlm.nih.gov/pubmed/18197164
SLOVAKIA
http://www.ncbi.nlm.nih.gov/pubmed/16835997
SPAIN
http://www.ncbi.nlm.nih.gov/pubmed/11903061
http://www.ncbi.nlm.nih.gov/pubmed/17675107
http://www.ncbi.nlm.nih.gov/pubmed/17202146
http://www.ncbi.nlm.nih.gov/pubmed/19425170
http://www.ncbi.nlm.nih.gov/pubmed/18454173
http://www.ncbi.nlm.nih.gov/pubmed/17065222
http://www.ncbi.nlm.nih.gov/pubmed/10700234
http://www.ncbi.nlm.nih.gov/pubmed/16787257
http://www.ncbi.nlm.nih.gov/pubmed/15958274
http://www.ncbi.nlm.nih.gov/pubmed/16139274
http://www.ncbi.nlm.nih.gov/pubmed/16624285
http://www.ncbi.nlm.nih.gov/pubmed/16616335
http://www.ncbi.nlm.nih.gov/pubmed/11269508
http://www.ncbi.nlm.nih.gov/pubmed/19690545
http://www.ncbi.nlm.nih.gov/pubmed/12511587
http://www.ncbi.nlm.nih.gov/pubmed/20307616
http://www.ncbi.nlm.nih.gov/pubmed/16818634
http://www.ncbi.nlm.nih.gov/pubmed/17952650
http://www.ncbi.nlm.nih.gov/pubmed/16818650
http://www.ncbi.nlm.nih.gov/pubmed/16596790
http://www.ncbi.nlm.nih.gov/pubmed/15638794
http://www.ncbi.nlm.nih.gov/pubmed/15275820
http://www.ncbi.nlm.nih.gov/pubmed/12133838
http://www.ncbi.nlm.nih.gov/pubmed/18339876
http://www.ncbi.nlm.nih.gov/pubmed/9771884
http://www.ncbi.nlm.nih.gov/pubmed/10570948
http://www.ncbi.nlm.nih.gov/pubmed/12182964
http://www.ncbi.nlm.nih.gov/pubmed/19229996
SWEDEN
http://www.ncbi.nlm.nih.gov/pubmed/19609004
http://www.ncbi.nlm.nih.gov/pubmed/16337199
http://www.ncbi.nlm.nih.gov/pubmed/16936228
http://www.ncbi.nlm.nih.gov/pubmed/18546271
SWITZERLAND
http://www.ncbi.nlm.nih.gov/pubmed/15453094
http://www.ncbi.nlm.nih.gov/pubmed/19589225
http://www.ncbi.nlm.nih.gov/pubmed/15047233
http://www.ncbi.nlm.nih.gov/pubmed/19509271
http://www.ncbi.nlm.nih.gov/pubmed/19480992
TAIWAN
http://www.ncbi.nlm.nih.gov/pubmed/18387516
THAILAND
http://www.ncbi.nlm.nih.gov/pubmed/19916793
UKRAINE
http://www.ncbi.nlm.nih.gov/pubmed/18438336
As much as I'd like to be excited about that, LATF is probably the most obvious MMJ scam stock. I'd love to be wrong about it being a scam, but I'd be shocked if I am.
It's in the works... When will they drop em?? Gotta love the drama. Take cover!
Tick, tick...
BK
SKTO says expect fins before the end of the Month! Tick tick...
BK
GoldNApel Blog Update 10-28-13
A Thank You from GoldNApel.
Hi Everybody,
Chuck and I wish to thank our loyal friends who communicate with each other on the (edit) message board. Along with the wonderful support, which we appreciate immensely, several of you have been putting together some excellent compilations of the science of medicinal cannabis, and presenting the information in a manner easily understandable by someone without scientific education.
This is incredibly important work that you are doing. It helps the cause immensely. The science is there. It has been proven over and over again. Virtually anyone who spends several hours reading the results of the studies that have shown the efficacy of cannabis in treating cancer has to agree that the potential is huge for the elusive "cure" lying somewhere in this amazing plant.
But lots of people have trouble understanding the language used in the scientific journals, and explaining what is presented in them in a manner understandable to the layman is the best way to show people the immense value of the science we are working with.
The medicinal efficacy of cannabis against cancer seems like a given with what has been proven to date. But in 2007, Science Daily headlined the results of a Harvard study with "Marijuana cuts lung cancer growth in half, study shows." Six years ago! Hardly any new research since then. No big push to find out if the Harvard docs were right. How many have died since Harvard ... that's Harvard!!! ... showed that cannabis is the most promising treatment for cancer being considered by medicine.
A few years earlier, the Harvard announcement would have triggered lot of research funding by the government - research designed to disprove what the doctors had just discovered. But the government quit this practice when they realized that they were unable to dispute the overwhelmingly-positive evidence shown by virtually every scientific study done by qualified researchers. In fact, when they funded UCLA's Dr. Donald Tashkin to carry out the scientific study to prove that long-term smoking cannabis caused cancer, and he showed that cannabis smokers had measurably less lung cancer than non-smokers, they cut back their funding even more. Now Dr. Tashkin is a speaker at pro-medical marijuana events.
So it is up to us. Six years since Harvard had such dramatic results, and they won't even give Doc Abrams some "official" Simpson oil, even after he personally observed 25 stage 4 cancer patients go into remission after its use.
I like to try to see the good in my fellow humans. I like to think that it is just the slow wheels of bureaucracy that has held back this research. I like to think that no human, with an ounce of compassion and humanity, could study the existing science and try to hold back its development for the sake of money. I like to think that no company, no government, no individual could be low enough to try to stifle the development of this science for the sake of personal or corporate profit, once they had studied the science for even one hour.
Perhaps one who is uneducated about the science, or has formed an opinion and does not want to look at the new evidence with an open mind, or does not want to consider a new point of view, perhaps they could continue to try to suppress this technology, but I don't see how anyone who has a reasonable level of intelligence, and has put even one hour into considering what the scientists have presented to date could try to hold this back.
So, I got off on a bit of a tangent, but it is very frustrating to me, as I am sure it is to those of you who have studied the science, seen the potential, and wonder, as I do, how anyone could try to hold this science down for the sake of money.
So as I was saying, I thank you for all your work compiling and explaining the information. If you have written something, or compiled some good information, or find a good link you think would work on our facebook page, please hang on to it for now. I will try to get a "Cool Scientific Submissions from Friends of Berkeley Bio" feature up on Facebook here soon.
And thank you all again. I am really looking forward to meeting many of you sometime down the road. Berkeley Bio / Dharma had a wonderful company picnic in Tilden Park, high on the ridge behind Berkeley, soon after we finalized our relationship with SK3. We are thinking that we will have another one there on the one year anniversary and invite all the friends of BBio and Sk3 and the Care and Hospice Program.
Dave
That is my feeling exactly! The "former accountant" was actually in some trouble recently in their work for a different company. My sense, and just an opinion, it that Bradford is concerned about the longevity of their own business, even for non-issues like AEGY consulting with someone that, "is not an officer, director, employee, shareholder, or agent of Registrant, does not and has never, practiced or appeared before the Commission as an accountant and does not prepare or manage the financial reports."
They just cut bait, and effectively swam upsteam away from AEGY and away from Pinks in general.
BK
...and that was with approximately 30 collectives. Now we have,
75.
BK
There's nothing abnormal about this...
Hang on! This is just the beginning!
$SKTO Hotel, Resort, and Casino on the way...
BK
Looks like new investors are helping and embracing the underlavuled PPS - with AWESOME financials on the way... Be prepared for a HUGE increase relaease on FINS!
BK